Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,510,757
Closed -$217M 126
2018
Q3
$217M Buy
5,510,757
+908,740
+20% +$40.9M 0.34% 73
2018
Q2
$226M Sell
4,602,017
-195,403
-4% -$11.1M 0.37% 69
2018
Q1
$287M Buy
4,797,420
+2,334,229
+95% +$156M 0.48% 59
2017
Q4
$194M Buy
2,463,191
+1,983,561
+414% +$160M 0.32% 74
2017
Q3
$40.3M Buy
479,630
+17,740
+4% +$1.26M 0.07% 102
2017
Q2
$30.2M Buy
461,890
+27,120
+6% +$1.84M 0.05% 103
2017
Q1
$31.6M Buy
434,770
+359,595
+478% +$23.6M 0.06% 102
2016
Q4
$4.41M Buy
+75,175
New +$3.97M 0.01% 112

Other funds holding ADNT

Bill Nygren's ADNT Position: Q4 2018 in Review

Bill Nygren sold out of Adient (ADNT) in Q4 2018, closing a stake of 5,510,757 shares — an estimated $217M sold.

Bill Nygren first reported a position in ADNT in Q4 2016 and held it in 8 quarters. The position peaked at $287M in Q1 2018. 348 funds tracked by Wall St. Rank hold ADNT as of Q4 2018.

  • Bill Nygren reported no remaining Adient position as of Q4 2018 after selling out during the quarter.
  • Bill Nygren sold 5,510,757 Adient shares in Q4 2018, an estimated $217M.
  • Bill Nygren first reported a position in Adient in Q4 2016 and held it in 8 quarters.
  • Bill Nygren's Adient position peaked at $287M in Q1 2018.
  • 348 funds tracked by Wall St. Rank held Adient as of Q4 2018.

Based on Harris Associates's 13F filing for Q4 2018, filed 14 Feb 2019.